Florian E. Scherer

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications

High-dose chemotherapy followed by autologous stem-cell transplantation versus non-myeloablative consolidation in primary CNS lymphoma (MATRix/IELSG43): a randomised phase 3 trial.

High-dose chemotherapy followed by autologous stem-cell transplantation versus non-myeloablative consolidation in primary CNS lymphoma (MATRix/IELSG43): a randomised phase 3 trial.

Journal: Lancet (London, England)
Published: February 19, 2026

Spatial and multi-omic profiling reveals pericyte-derived CCL19 as a key prognostic factor in CNS lymphoma.

Spatial and multi-omic profiling reveals pericyte-derived CCL19 as a key prognostic factor in CNS lymphoma.

Journal: HemaSphere
Published: January 20, 2026

The Phase Ib VenObi CNS Study: Chemotherapy-Free Treatment with Venetoclax and Obinutuzumab for Relapsed/Refractory Primary Large B-Cell Lymphoma of the Central Nervous System.

The Phase Ib VenObi CNS Study: Chemotherapy-Free Treatment with Venetoclax and Obinutuzumab for Relapsed/Refractory Primary Large B-Cell Lymphoma of the Central Nervous System.

Journal: Cancers
Published: December 23, 2025

Cracking the POD24 code in follicular lymphoma.

Cracking the POD24 code in follicular lymphoma.

Journal: Blood
Published: August 21, 2025

Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention.

Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention.

Journal: Cancer cell
Published: July 04, 2025

Guiding clinical management of patients with CNS lymphomas by minimal-invasive detection of ctDNA in cerebrospinal fluid.

Guiding clinical management of patients with CNS lymphomas by minimal-invasive detection of ctDNA in cerebrospinal fluid.

Journal: Leukemia
Published: January 24, 2025

The effect of ibrutinib on the myeloid cell compartment in CNS lymphoma.

The effect of ibrutinib on the myeloid cell compartment in CNS lymphoma.

Journal: Leukemia
Published: January 24, 2025

Intraoperative classification of CNS lymphoma and glioblastoma by AI-based analysis of Stimulated Raman Histology (SRH).

Intraoperative classification of CNS lymphoma and glioblastoma by AI-based analysis of Stimulated Raman Histology (SRH).

Journal: Brain & spine
Published: September 15, 2024

Advanced diffusion imaging reveals microstructural characteristics of primary CNS lymphoma, allowing differentiation from glioblastoma.

Advanced diffusion imaging reveals microstructural characteristics of primary CNS lymphoma, allowing differentiation from glioblastoma.

Journal: Neuro-oncology advances
Published: July 01, 2024

Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors.

Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors.

Journal: NPJ precision oncology
Published: April 29, 2024

Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review.

Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review.

Journal: Neuro-oncology
Published: April 10, 2024

High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial.

High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial.

Journal: The Lancet. Haematology
Published: October 02, 2023
Showing 1-12 of 59

Last Updated: 09/26/2026